other material
confidence high
sentiment neutral
materiality 0.50
FibroBiologics reports $3.9M gross proceeds from GEM equity line draw downs
FibroBiologics, Inc.
- On Aug 26, 2024, sold 100,000 shares at net $4.51 (10% discount), gross $451K.
- Prior draw down: 840,000 shares at net $4.09, gross $3,436K; 560,000 shares returned for cancellation.
- Aggregate gross proceeds from GEM SPA subsequent to June 30, 2024: $3,887K.
- Remaining 1,500,000 shares from July 12 draw down returned to Company and cancelled.